arsenic trioxide has been researched along with Hodgkin Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hao, L; Wang, H; Wang, X; Xu, G; Zhao, J | 1 |
| Bommert, K; Dorken, B; Hinz, M; Janz, M; Jundt, F; Lietz, A; Mathas, S; Scheidereit, C | 1 |
2 other study(ies) available for arsenic trioxide and Hodgkin Disease
| Article | Year |
|---|---|
Hepatotoxicity from arsenic trioxide for pediatric acute promyelocytic leukemia.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Child; Hodgkin Disease; Humans; Leukemia, Promyelocytic, Acute; Liver; Male; Oxides | 2013 |
Inhibition of NF-kappaB essentially contributes to arsenic-induced apoptosis.
Topics: Animals; Apoptosis; Arsenic; Arsenic Trioxide; Arsenicals; Arsenites; Down-Regulation; Gene Expression Profiling; Hodgkin Disease; Humans; I-kappa B Kinase; Mice; Mice, SCID; NF-kappa B; Oxides; Protein Serine-Threonine Kinases; Reed-Sternberg Cells; Sodium Compounds; Transplantation, Heterologous; Tumor Cells, Cultured | 2003 |